Tirzepatide Reduces Asthma Flare-Up Risk in Diabetes Patients

Tirzepatide reduces asthma flare-up risk in diabetes patients, according to a study comparing it with semaglutide.

Adults with polycystic ovary syndrome may show brain changes on imaging, but a direct link to Alzheimer's disease…

A meta-analysis that appeared in JAMA Cardiology demonstrates that aggressively lowering blood pressure reduces the occurrence of major…

Healthcare leaders say shifting from a perfection mindset to a learning culture reduces fear of errors and promotes…

The American Society of Nephrology Kidney Week 2026 convened in Denver from Oct. 21-25, drawing clinicians and researchers…

The U.S. Food and Drug Administration is expected to issue its decision before the close of 2026 on…

AI raises concerns in healthcare systems, potentially worsening disparities if biases go unchecked, about ai healthcare.

FDA approves new hepatitis B treatment bepirovirsen (Hibsago) by GSK for adults with chronic HBV infection.

The FDA has expanded the approval of tildrakizumab for adults with active psoriatic arthritis, adding to its use…

Tenet Healthcare raises 2026 earnings guidance by focusing on high-value surgeries, stabilizing finances amid weak surgical market and…